SURMOUNT-2: new advances for treating obese type 2 diabetes with tirzepatide. Frandsen CS, Madsbad S. Lancet 2023 Jun 26:S0140-6736(23)01292-8. doi: 10.1016/S0140-6736(23)01292.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frandsen CS, Madsbad S. SURMOUNT-2: new advances for treating obese type 2 diabetes with tirzepatide. Lancet 2023 Jun 26:S0140-6736(23)01292-8. doi: 10.1016/S0140-6736(23)01292.
PMID: 37385274